A woman born in 1970 can expect to spend one-third of her life post-menopause. The climacteric period can be challenging for both patients and health care providers, with menopausal symptoms and the physical effects of oestrogen deficiency accounting for a significant proportion of primary care consultations. The use of hormone replacement therapy (HRT) remains a controversial topic and misleading information is widespread. Good management of post-reproductive health can have a significant impact on a woman’s current and future well-being. This article aims to provide an overview of the physical, psychological and social consequences of menopause, the menopause consultation and the role of HRT in its management.
Get full access to this article
View all access options for this article.
References
1.
British Menopause Society. (2006). Management of the menopause. Integrated healthcare pathway for the menopausal woman.
CanonicoM.ScarabinP. Y. (2009) Hormone therapy and risk of venous thromboembolism among postmenopausal women. Climacteric12(S1): 76–80.
5.
Collaborative Group on Epidemiological Studies of Ovarian Cancer. (2015). Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Retrieved from www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61687-1/abstract.
6.
DavisS. R.Castelo-BrancoC.ChedrauiP.LumsdenM. A.NappiR. E.ShahD.VillasecaP. (2012) Understanding weight gain at menopause. Climacteric15(5): 419–429doi: 10.3109/13697137.2012.707385.
7.
GrayS. (2014) Practice observed. Post Reproductive Health20(3): 122–123.
8.
HamodaH.SavvasM. (2014) What should we be advising women about hormone replacement therapy?InnovAiT7(5): 295–300. doi: 10.1177/1755738014522987.
9.
HarmanS. M.BrintonE. A.CedarsM.LoboR.MansenJ.MerriamJ. R.SantoroN. (2005) KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric8(1): 3–12.
10.
HulleyS.GradyD.BushT.FurbergC.HerringtonD.RiggsB.VittinghoffE. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association280: 605–613.
Islam, R., & Cartwright, R. (2011). The impact of premature ovarian failure on quality of life: Results from the UK 1958 birth cohort. In: 27th annual meeting of the European Society of Human Reproduction and Embryology, pp. I108–I108. Oxford, UK: Oxford University Press.
Joint Formulary Committee (2014) British national formulary, London, UK: BML Group and Pharmaceutical Press.
15.
Lethaby, A., Hogervorst, E., Richards, M., Yesufu, A., & Yaffe, K. (2008). Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Systematic Reviews, 1, art. no.: CD003122. doi: 10.1002/14651858.CD003122.pub2.
16.
L'HermiteM. (2013) HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. Climacteric16(S1): 44–53. doi: 10.3109/13697137.2013.808563.
Office for National Statistics. (2012). 2011 Census: Population estimates for the United Kingdom, 27 March 20ll. Retrieved from www.ons.gov.uk/ons/dcp171778_292378.pdf.
25.
PanayN.HamodaH.AryaR.SavvasM. (2013) The 2013 British Menopause Society & Women’s Health Concern recommendations on hormone replacement therapy. Menopause International19(2): 59–68. doi: 10.1177/1754045313489645.
26.
PanayN.MaamariR. (2012) Review: Treatment of postmenopausal vaginal atrophy with 10-ug estradiol vaginal tablets. Menopause International18(1): 15–19. doi: 10.1258/mi.2012.011120.
ReesM.StevensonJ.HopeS.RozenbergS.PalaciosS. (2011) Management of the menopause, fifth edition. Boca Raton: FL: CRC Press.
30.
RiggC. (2012) Common problems of the menopause. InnovAiT5(9): 541–546. doi: 10.1093/innovait/ins075.
31.
RyanJ.ScaliJ.CarrièreI.AmievaH.RouaudO.BerrC.AncelinM. L. (2014) The impact of menopause on cognitive function in later life. BJOG121(13): 1729–1739. doi: 10.1111/1471-0528.12828.
32.
SchierbeckL. L.RejnmarkL.ToftengC. L.StilgrenL.EikenP.MosekildeL.JensenJ. E. (2012) Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: Randomised trial. British Medical Journal9(345): e6409doi: 10.1136/bmj.e6409.
